Institutional and Fund Ownership
|Security||PPHMP / Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock|
|President & CEO||KING STEVEN W|
PPHM / Peregrine Pharmaceuticals, Inc.|
Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) has 3 institutional investors that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 426,998 shares. Major holders include Perceptive Advisors Llc , Stafford John S Iii , and Ronin Capital, LLC .
Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Owners can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions.
|File Date||Form||Investor||Opt||Prev Shares||Current Shares||Change
|Prev Value (x$1000)||Current Value (x$1000)||Change|
|PERCEPTIVE ADVISORS LLC||*||200,000||200,000||0.00||3,982||4,342||9.04|
|SC 13D/A||STAFFORD JOHN S III||*||115,299|
|SC 13D/A||Ronin Capital, LLC||*||95,059||111,699||17.50|
|Burt Wealth Advisors||*||600||0||-100.00||12||0||-100.00|
Fintel IR - Find the Right Investors for Your Company, Instantly!Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!
Join our private investing channel!Request Membership